Clinical Trial Update: Treprostinil Combined With Tadalafil for Pulmonary Hypertension [Phase 4]

View source ↗

Summary

This update reports the termination of a Phase 4 trial evaluating the combination of treprostinil and tadalafil for pulmonary arterial hypertension, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Remodulin (treprostinil)
• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Rhode Island Hospital | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2013-07-18